(Q36499270)

14 August 2017

title

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma (English)

1 reference

14 August 2017

author

Julie Teruya-Feldstein

3

Julie Teruya-Feldstein

0 references

Paul Hamlin

Paul Hamlin

4

0 references

Andrew D Zelenetz

Andrew D Zelenetz

2

0 references

Joachim Yahalom

5

Joachim Yahalom

1 reference

14 August 2017

Tarun Kewalramani

1

1 reference

14 August 2017

Steven Horwitz

6

1 reference

14 August 2017

Stephen D Nimer

7

1 reference

14 August 2017

Craig H Moskowitz

8

1 reference

14 August 2017

language of work or name

English

0 references

publication date

6 June 2006

1 reference

British Journal of Haematology

14 August 2017

published in

1 reference

14 August 2017

volume

134

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

202-207

1 reference

Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06164.X

10.1111/J.1365-2141.2006.06164.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference